The aim of the North Cumbria Community Genetics Project is to establish a store of DNA, plasma, and viable cells from a cohort of around 8000 Cumbrian infants. To meet this objective, specimens of umbilical cord blood and tissue will be collected with maternal consent from babies born at the West Cumberland Hospital, Whitehaven over a five year period from January 1996. These samples will be used in a series of genetic and epidemiological studies investigating the interaction between genes, the environment, and health. There is little population movement in West Cumbria and so it will be possible to follow many of the babies throughout their childhood and to investigate the relationship between their genetic constitution and health outcome.
An international effort is under way to sequence the whole of the human genome (Human Genome Project) and there are confident predictions that by the year 2005 the entire genome will be mapped and all the genes (about 80 000 in total) will be identified. ' The next task will be to assign functions to the genes. Mutations in some genes will be sufficient in themselves to cause disease; however, many diseases, including most cancers, are the result of interactions between susceptibility genes and factors in the environment. These multifactorial diseases affect a large proportion of the population. Heart disease, for example, affects about half of the population over 65 years of age and is the single most common cause From the beginning it was recognised that for this innovative study, ethical debate, both with professionals and the public, would be required to gain the goodwill and support necessary for success. Before the project could proceed it required careful planning and preparation. Information leaflets, consent forms, and questionnaires were produced and the logistics of distributing these and collecting samples were established with regard to antenatal care and midwifery practices operating in the area. Technical aspects of sample collection and storage were devised and procedures developed to ensure that confidentiality of the data was safeguarded at all times. In the event it was not until January 1996, several years after the idea was initially conceived, that sample collection began. Criticism of the project has been associated almost exclusively with concern over a local issue, the involvement of the nuclear industry. It is acknowledged that without the support of British Nuclear Fuels plc (BNFL), which operates a nearby nuclear installation at Sellafield, this project could not have been initiated. BNFL is committed to the investigation of any impact its activities could potentially have on the local environment. Following the report by Gardner et af showing a statistical association between paternal preconceptional irradiation received occupationally at the Sellafield reprocessing plant and the development of childhood leukaemia, considerable effort was expended in developing child health studies in the area. Some of these studies have been reported8 9 and are consistent with the realisation that the association does not represent a plausible causal mechanism.'" Factors related to the nuclear industry will of necessity be part of the environmental and occupational characteristics of the local population, but the project has a much wider remit and will focus on geneenvironment interaction in the aetiology and pathogenesis of disease. BNFL have no role in the management of the project and have not sought such a role.
Because of the unique nature of the project and the lack of published guidelines, a number of recognised UK experts with experience in the ethics of genetic and epidemiological studies were invited to form an Ethics Advisory The primary aim ofthe project is to gain health benefits from the study of genes in the population. The overriding concern of the North Cumbria Community Genetics Project team is to safeguard confidentiality and minimise the possibility of harm to individual people or the community. Every application for research using these samples will be considered with regard to current views and medical developments, and approval sought from the West Cumbria Local Research Ethics Committee. There are three categories of study that need to be distinguished.
(1) Studies that use anonymous samples to determine the frequencies of alleles at specific loci or of polymorphism variants. Subject to (3) below, there are likely to be few ethical difficulties with the use of NCCGP samples for such work, and such anonymous samples (or DNA extracted from them) may be released to other groups subject to appropriate conditions, including the precise specification of the uses to which the samples will be put and the acknowledgement of the source of the samples. Previous discussion of such studies by the Ethics Advisory Group is not necessary, although the Group will be informed of any such arrangements that are made. (2) Studies that involve linkage to data on individual subjects. These specific studies will be considered by the Ethics Advisory Group. Identification of individual people during the process and reporting of any such study will be done in such a way as to safeguard confidentiality. (3) This is not a screening programme and individual results are not reported back to the participants. Diagnosis of any health related problem will still be through family doctors and the National Health Service, and is likely to be in advance of any population study using these samples. In rare and extreme circumstances when there may be an immediate major health benefit, the West Cumbria Local Research Ethics Committee would be asked to consider whether it is in the family's interest for an individual result to be disclosed.
SAMPLE COLLECTION AND PROCESSING
After the birth of the baby, the hospital midwives take specimens of cord blood and cord tissue and place them in numbered tubes which are sent to the laboratory at Westlakes Research Institute. In order to accommodate future studies, a wide variety of samples is being banked (whole blood, plasma, extracted DNA, cultured lymphocytes, and chopped cord as a source of viable cells), all of which are stored frozen.
Progress
Recruitment of pregnant women into the project began in January 1996. Currently, about 90% of pregnant women approached agree to participate. Of those giving consent, about 60% complete all or part of a mother's questionnaire. A preliminary analysis of the postcode data indicates that the distribution pattern of these women reflects the main centres of population and does not appear to vary significantly with geographical location. By November 1997, over 2500 women had been recruited, almost 2000 samples collected, and 1200 questionnaires collated.
The difficulties we have encountered so far have largely been of a practical nature. There is no central booking system in West Cumbria and pregnant women can attend one of many antenatal clinics at various geographical locations. The current trend is towards community based antenatal care: many pregnant women now carry their own obstetric notes and may only come to a hospital clinic once or twice in their first pregnancy, and possibly not at all for subsequent uncomplicated pregnancies. The project liaison midwife has proved to be essential in providing the interface for recruitment and overcoming these difficulties. Occasionally samples have not been collected by the midwives owing to the uneven work load on the labour ward, unexpected complications, or an emergency delivery, but this is rare.
Future studies A wide range of health related research studies could benefit from access to these samples. In consultation with the Ethics Advisory Group, a "Statement on Acceptable Research Uses of Collected Samples" has been drawn up (table  1) . Some studies may use the samples totally anonymously, for example to estimate the number of people in the population who have a specific genetic polymorphism. Other studies may need to link laboratory test data with information contained in the mother's questionnaire or with medical records of the mother or child. Whatever type of study is undertaken, the results will be published such that no individual person can be identified.
Currently, two research studies have been approved by the West Cumbria Local Research Ethics Committee. One uses the glycophorin-A assay and estimates the number of somatic mutations affecting the gene for the MN blood group antigen. The other is a study of a microdeletion on chromosome 22, associated with DiGeorge syndrome. The results of each study will be reported at a later date.
Conclusion
The increasing awareness of the importance of gene-environment interaction in the aetiology of a wide range of diseases has led to a need for population based studies capable of linking epidemiological, genetic, and health outcome data. The North Cumbria Community Genetics Project has been set up to meet this objective.
